United States· US:0006-5092_36245cd8-5e98-408c-a2df-38f9642b0827
IDVYNSO
A medicinal product containing doravirine; islatravir anhydrous, registered in United States by Merck Sharp & Dohme LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DORAVIRINE; ISLATRAVIR ANHYDROUS
- Manufacturer
- Merck Sharp & Dohme LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc110006-5092-01
- ndc110006-5092-59
- ndc11000650920130 TABLET, FILM COATED in 1 BOTTLE (0006-5092-01)
- ndc11000650925914 TABLET, FILM COATED in 1 BOTTLE (0006-5092-59)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1e9aab69-b246-482c-9089-cf8dc86b30da GET /v1/drugs/1e9aab69-b246-482c-9089-cf8dc86b30da?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100; .25",
"substance": "DORAVIRINE; ISLATRAVIR ANHYDROUS",
"productndc": "0006-5092",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "NDA216964",
"marketing_category": "NDA"
}See everything about doravirine; islatravir anhydrous.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.